Michaeleen Doucleff | KGOU
KGOU

Michaeleen Doucleff

Michaeleen Doucleff is a reporter for NPR's Science Desk. She reports for the radio and the Web for NPR's global health and development blog, Goats and Soda. Doucleff focuses on disease outbreaks, drug development, and trends in global health.

In 2014, Doucleff was part of the team that earned a George Foster Peabody award for its coverage of the Ebola outbreak in West Africa. For the series, Doucleff reported on how the epidemic ravaged maternal health and how the virus spreads through the air. In 2015, Doucleff and Senior Producer Jane Greenhalgh reported on the extreme prejudices faced by young women in Nepal when they're menstruating. Their story was the second most popular one on the NPR website in 2015 and contributed to the NPR series on 15-year-old girls around the world, which won two Gracie Awards.

As a science journalist, Doucleff has reported on a broad range of topics, from vaccination fears and the microbiome to beer biophysics and dog psychology.

Before coming to NPR in 2012, Doucleff was an editor at the journal Cell, where she wrote about the science behind pop culture. Doucleff has a doctorate in chemistry from the University of Berkeley, California, and a master's degree in viticulture and enology from the University of California, Davis.

Back in April, COVID-19 hit the city of Manaus, Brazil, extremely hard. In fact, the outbreak there was arguably the worst in the world. One study, published in the journal Science, estimated that so many people were infected that the city could have reached herd immunity — that the outbreak there slowed down because up to 76% of the population had protection against the virus.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

ARI SHAPIRO, HOST:

When Vice President-elect Kamala Harris was on the campaign trail in 2019, she loved entering events with the energy of a drum line.

(SOUNDBITE OF DRUM LINE DRUMMING)

Updated Friday Jan. 15, 7:35 p.m.

A highly contagious version of the coronavirus is rapidly spreading across the U.S., the Centers for Disease Control and Prevention reports Friday.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

AILSA CHANG, HOST:

Here in the U.S., communities see a light at the end of the COVID-19 tunnel. With the vaccinations now occurring across the country, health officials are optimistic that the outbreak could be under control by the end of this year.

But the pandemic won't be over. Across the globe, the virus will still be circulating widely, even surging, in many countries.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

SCOTT SIMON, HOST:

A new variant of the coronavirus is sweeping through England. At the same time, the country is reporting a record-high number of COVID-19 cases – nearly 40,000 on Wednesday — as well as surges in hospitalizations and deaths. In London last week, an estimated 2% of people in private households tested positive for the coronavirus, The Independent reported.

So the big question is: Are these events connected? Is the new variant causing this surge?

A new variant of the coronavirus is spreading rapidly in England and raising international alarms. This new variant now accounts for more than 60% of the cases in London. And scientists say the variant is likely more contagious than previous versions of the virus.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

DAVID GREENE, HOST:

COVID-19 is now the second-leading cause of death in the U.S. for 2020. The virus has killed more than 90 people per 100,000, reports Johns Hopkins University.

But in other parts of the world, the virus hasn't been such a big problem. It's not a top killer. Some global health experts are beginning to ask whether immunizing large swaths of the population is the best use of resources for these countries.

Loading...

Health care workers first, along with residents and staff of nursing homes. Those people should receive the COVID-19 vaccine before anyone else, the U.S. Centers for Disease Control and Prevention said Tuesday.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

ARI SHAPIRO, HOST:

Why does a disease hit some countries or regions hard and largely spares others?

For example, the virus that causes COVID-19 has surged so strongly in North and South America. But it has been less of a problem in Africa and many parts of Asia.

This week, the world heard encouraging news about a vaccine for COVID-19.

On Monday, the pharmaceutical company Pfizer, and its partner BioNTech, said their experimental vaccine appears to work – and work quite well. A preliminary analysis suggests the vaccine is more than 90 percent effective at preventing COVID-19 symptoms.

Health officials hope to start vaccinating some Americans in a few months.

Rich countries are rapidly claiming the world's lion's share of future doses of COVID-19 vaccine, creating deep inequalities in global distribution.

Despite an international agreement to allocate the vaccine equitably around the world, billions of people in poor and middle-income countries might not be immunized until 2023 or even 2024, researchers at Duke University predict.

As wildfires raged up and down the Pacific Coast last month, families across California and Oregon lived in – and breathed in — smoky, toxic air for weeks. Many days, the region's air quality ranked among the worst in the world.

Early in the coronavirus pandemic, air travel looked like a risky endeavor. Some scientists even worried that airplanes could be sites of superspreading events. For example, in March a Vietnamese businesswoman with a sore throat and a cough boarded a flight in London. Ten hours later, she landed in Hanoi, Vietnam; she infected 15 people on the flight, including more than half of the passengers sitting with her in business class.

Copyright 2020 NPR. To see more, visit https://www.npr.org.

NOEL KING, HOST:

In case you were still procrastinating getting a flu shot this year, here's another reason to make it a priority.

There's a chance the vaccine could offer some protection against COVID-19 itself, says virologist Robert Gallo, who directs the Institute of Human Virology at the University of Maryland School of Medicine and is chairman of the Global Virus Network.

Copyright 2020 NPR. To see more, visit https://www.npr.org.

DAVID GREENE, HOST:

Pages